EPO Quality Report 2018
12 Jul 2019
July has seen the publishing of the European Patent Office’s (EPO) 2018 Quality Report. This is the first to be released under the direction of the EPO’s.
New Rules of Procedure at the Boards of Appeal – what does this mean for patentees and opponents?
09 Jul 2019
Revised Rules of Procedure at the Boards of Appeal have been approved by The Administrative Council of the EPO. The Rules will come into force on 1.
Medicinal cannabis: recent changes and future innovations
18 Jun 2019
Government policy on the prescription of cannabis-derived medicines has undergone some interesting and important changes over the past few months, both in.
EU approves first gene therapy for patients with a mild form of β-Thalassemia
04 Jun 2019
Exciting news in the personalised medicine space – the EU has just approved the first gene therapy for patients with a mild form of β-Thalassemia. .
Precision therapeutics for the precision medicine era
17 May 2019
In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.
Personalised medicine: patient stratification
29 Apr 2019
While the general idea of customising treatment to patients is not new, the degree to which treatments may be tailored to patient subgroups defined by.
Pioneers of precision medicine
15 Apr 2019
Breakthroughs in healthcare promise a future in which the individual sits at the centre of medical decisions. But who has paved the way and who is leading.
Hydrogen: the storage question
04 Apr 2019
There’s a lot to like about hydrogen. It’s light; it’s abundant (at least atomically - water and hydrocarbons contain plenty of hydrogen atoms); it’s.
Building an effective drug franchise: A Transatlantic perspective - April 23, Boston, MA
02 Apr 2019
It's never too early, or too late, to start thinking about managing the life cycle of exclusivity and getting the most value from your discoveries . In.
The road to autonomous
28 Mar 2019
Dosage regimen patents: bruised but not beaten
28 Mar 2019
Ruling on the big pharma Actavis v ICOS case, the UK Supreme Court has found ICOS’s Cialis patent to be invalid for obviousness.
Playing for time: strategies that can help extend a drug's patent life
25 Mar 2019
Former CITMA President Kate O’Rourke to head our European trade mark services
11 Mar 2019
We are delighted to announce that Kate O’Rourke will join the firm on 1 April 2019.
Can the EPO hold oral proceedings in Haar without infringing a party’s right to be heard? A new referral to the Enlarged Board raises this question.
06 Mar 2019
The right to be heard under Article 113(1) EPC requires that parties involved in proceedings before the EPO have the right to present their arguments at.
Bioinformatics Inventions: Patenting challenges at the interface of computer and life sciences
27 Feb 2019
We are entering an age of precision medicine, with patients receiving tailored treatments, selected and sometimes even specifically designed for their.
How to patent AI technology at the EPO
26 Feb 2019
Once only a figment of the imagination in literature such as Mark Shelley’s Frankenstein, artificial intelligence, commonly known as AI, is now realised.
Self-driving vehicles: what do consumers think (and want)?
25 Feb 2019
As a survey of 25,000 consumers in 20 countries, and a study that has been conducted annually over the past ten years, the Deloitte Global Automotive.
Is your interest legitimate? New referral to the EBOA on double patenting
22 Feb 2019
EPO Board of Appeal 3.3.01 is referring a number of questions regarding double patenting to the Enlarged Board of Appeal. The answers may force.
Building an IP portfolio: Nine tips for success
15 Feb 2019
Companies need to think carefully about how they protect, manage and leverage the various intellectual property (IP) assets across their business..